Skip to content
MedsAcross

Brand family

Oseni

Alogliptin and Pioglitazone · Takeda Pharmaceuticals
United States
Presentations
4
Markets
1

Oseni is a brand of Alogliptin and Pioglitazone marketed by Takeda Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Alogliptin and Pioglitazone
Brand owner
Takeda Pharmaceuticals
Registered in
United States
Strengths and forms
12.5 mg/30 mg tablet, 25 mg/15 mg tablet, 25 mg/30 mg tablet, 25 mg/45 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Oseni 12.5 mg/30 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Oseni 25 mg/15 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Oseni 25 mg/30 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request
Oseni 25 mg/45 mg tabletOralTakeda PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Oseni

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.